🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 18 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 12/06/2014 | 41,72 | 41,80 | 41,10 | 41,55 | -1,08% | 1,66% | 221.535 |
| 11/06/2014 | 42,76 | 43,18 | 41,61 | 42,01 | -2,72% | 3,66% | 228.428 |
| 10/06/2014 | 42,76 | 43,45 | 42,66 | 43,18 | +0,84% | 1,85% | 229.870 |
| 09/06/2014 | 42,49 | 44,57 | 42,05 | 42,82 | +1,03% | 5,92% | 423.032 |
| 06/06/2014 | 43,11 | 43,11 | 42,13 | 42,38 | -1,41% | 2,27% | 244.938 |
| 05/06/2014 | 42,53 | 43,11 | 41,83 | 42,99 | +2,04% | 2,99% | 253.434 |
| 04/06/2014 | 41,22 | 42,19 | 40,77 | 42,13 | +1,58% | 3,44% | 184.986 |
| 03/06/2014 | 42,71 | 43,00 | 41,39 | 41,47 | -3,12% | 3,77% | 420.307 |
| 02/06/2014 | 41,57 | 43,01 | 40,71 | 42,81 | +2,86% | 5,52% | 492.762 |
| 30/05/2014 | 42,13 | 42,39 | 40,82 | 41,62 | -0,48% | 3,72% | 440.024 |
| 29/05/2014 | 42,02 | 42,05 | 41,57 | 41,82 | +0,25% | 1,13% | 261.770 |
| 28/05/2014 | 41,77 | 42,09 | 40,94 | 41,71 | -0,36% | 2,76% | 252.473 |
| 27/05/2014 | 41,63 | 42,11 | 41,22 | 41,86 | +1,44% | 2,13% | 338.874 |
| 23/05/2014 | 40,64 | 41,47 | 40,27 | 41,27 | +1,63% | 2,96% | 175.208 |
| 22/05/2014 | 39,46 | 41,17 | 39,15 | 40,61 | +3,01% | 5,11% | 248.465 |
| 21/05/2014 | 39,36 | 39,92 | 38,72 | 39,42 | +0,67% | 3,04% | 155.972 |
| 20/05/2014 | 40,34 | 40,34 | 38,68 | 39,16 | -3,45% | 4,11% | 259.045 |
| 19/05/2014 | 40,11 | 41,53 | 39,68 | 40,56 | +0,37% | 4,62% | 293.670 |
| 16/05/2014 | 39,96 | 40,54 | 38,79 | 40,41 | +1,41% | 4,37% | 266.419 |
| 15/05/2014 | 39,10 | 40,34 | 37,75 | 39,84 | +0,95% | 6,62% | 334.226 |
| 14/05/2014 | 39,93 | 40,54 | 38,71 | 39,47 | -1,20% | 4,59% | 249.427 |
| 13/05/2014 | 40,58 | 41,37 | 39,64 | 39,95 | -1,48% | 4,24% | 251.190 |
| 12/05/2014 | 38,37 | 41,62 | 38,37 | 40,55 | +3,45% | 8,47% | 335.187 |
| 09/05/2014 | 38,71 | 39,41 | 37,73 | 39,20 | +1,06% | 4,34% | 266.419 |
| 08/05/2014 | 40,52 | 42,40 | 38,58 | 38,78 | -4,90% | 9,41% | 437.940 |
| 07/05/2014 | 38,99 | 40,83 | 37,67 | 40,78 | +2,06% | 8,10% | 696.984 |
| 06/05/2014 | 40,52 | 40,89 | 39,71 | 39,96 | -1,61% | 2,91% | 467.435 |
| 05/05/2014 | 38,36 | 40,80 | 38,16 | 40,61 | +4,54% | 6,88% | 286.777 |
| 02/05/2014 | 39,59 | 39,59 | 38,42 | 38,85 | -1,88% | 2,96% | 389.850 |
| 01/05/2014 | 39,39 | 40,44 | 38,56 | 39,59 | +0,46% | 4,78% | 699.549 |